Cellular immunity aberrations in patients with SLE are underscored by the abnormal early Ag receptor-mediated lymphocyte signal transduction pathway. To further characterize the T cell receptor (TCR)/CD3-initiated signaling defects, we studied 22 patients with SLE, 12 patients with other systemic rheumatic diseases, and 14 normal donors. The early (1 min) TCR/CD3-mediated tyrosine phosphorylation of cellular proteins with a molecular size between 36 and 64 kD was increased in 15 of 21 SLE patients, compared to normal or disease control subjects. The deficiency or absence of a band with a molecular size of approximately 16 kD in the immunoblots of SLE patients led us to investigate the expression of the TCRzeta chain. In immunoblots using anti-zeta antibodies we found that 10 of 22 lupus patients tested lacked the expression of TCRzeta, which was always present in control subjects (P < 0.001). Flow cytometric studies using permeabilized cells confirmed the deficiency or absence of the TCRzeta chain in lupus T cells. Using Northern blots we found that for eight patients tested, the TCRzeta mRNA was missing in three, decreased in three, and apparently normal in two patients (P < 0.003), but was always present in control subjects. Reverse transcriptase-PCR verified Northern blot results. We conclude that TCRzeta chain expression is either decreased or absent in the majority of patients with SLE, but not in patients with other systemic rheumatic diseases, regardless of disease activity, treatment status, or clinical manifestations. The previously described increases in TCR-initiated Ca2+ responses and the herein described increases in TCR-induced protein tyrosine phosphorylation and deficient TCRzeta expression may represent intrinsic defects modulating lupus T cell function.
S N Liossis, X Z Ding, G J Dennis, G C Tsokos
Title and authors | Publication | Year |
---|---|---|
Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus
S Krishnan, MP Nambiar, VG Warke, CU Fisher, J Mitchell, N Delaney, GC Tsokos |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Targeting CD40L: a promising therapeutic approach
D Daoussis, AP Andonopoulos, SN Liossis |
Clinical and diagnostic laboratory immunology | 2004 |
Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity
A Perl, P Gergely, G Nagy, A Koncz, K Banki |
Trends in Immunology | 2004 |
DISSECTING THE MOLECULAR MECHANISMS OF TCR ζ CHAIN DOWNREGULATION AND T Cell SIGNALING ABNORMALITIES IN HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS
MP Nambiar, YT Juang, S Krishnan, GC Tsokos |
International Reviews of Immunology | 2004 |
Association of a four-amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: Molecular and functional analysis
J Otsuka, T Horiuchi, S Yoshizawa, H Tsukamoto, T Sawabe, Y Kikuchi, D Himeji, T Koyama, H Mitoma, T Watanabe, M Harada |
Arthritis & Rheumatism | 2004 |
DECREASED T CELL ERK PATHWAY SIGNALING MAY CONTRIBUTE TO THE DEVELOPMENT OF LUPUS THROUGH EFFECTS ON DNA METHYLATION AND GENE EXPRESSION
K Oelke, B Richardson |
International Reviews of Immunology | 2004 |
ALTERED EXPRESSION OF THE T CELL RECEPTOR-CD3 COMPLEX IN SYSTEMIC LUPUS ERYTHEMATOSUS
T Takeuchi, K Tsuzaka, T Abe |
International Reviews of Immunology | 2004 |
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
M Baniyash |
Nature Reviews Immunology | 2004 |
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha
JM Clark, AE Annenkov, M Panesar, P Isomäki, Y Chernajovsky, AP Cope |
Proceedings of the National Academy of Sciences | 2004 |
MITOCHONDRIAL DYSFUNCTION IN T CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
A Perl, P Gergely, K Banki |
International Reviews of Immunology | 2004 |
l-Arginine modulates CD3ζ expression and T cell function in activated human T lymphocytes
AH Zea, PC Rodriguez, KS Culotta, CP Hernandez, J DeSalvo, JB Ochoa, HJ Park, J Zabaleta, AC Ochoa |
Cellular Immunology | 2004 |
Decreased expression of CD28 coincides with the down-modulation of CD3zeta and augmentation of caspase-3 activity in T cells from hepatocellular carcinoma-bearing patients and hepatitis C virus-infected patients
A Maki, M Matsuda, M Asakawa, H Kono, H Fujii, Y Matsumoto |
Journal of Gastroenterology and Hepatology | 2004 |
T lymphocytes in systemic lupus erythematosus: an update
VC Kyttaris, GC Tsokos |
Current Opinion in Rheumatology | 2004 |
Masking of the CD3γ di-Leucine-based Motif by ζ is Required for Efficient T-Cell Receptor Expression
JP Lauritsen, CM Bonefeld, M Essen, MW Nielsen, AB Rasmussen, N Ødum, J Dietrich, C Geisler |
Traffic | 2004 |
Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice
D Sun, A Krishnan, J Su, R Lawrence, K Zaman, G Fernandes |
Cellular Immunology | 2004 |
T lymphocytes in systemic lupus erythematosus: an update:
VC Kyttaris, GC Tsokos |
Current Opinion in Rheumatology | 2004 |
Costimulation Blockade in the Treatment of Rheumatic Diseases:
SN Liossis, PP Sfikakis |
BioDrugs | 2004 |
Infection and Autoimmunity
C Dugué, Y Renaudineau, P Youinou |
Infection and Autoimmunity | 2004 |
Principles of Gender-Specific Medicine
G Supinski, LA Callahan |
Principles of Gender-Specific Medicine | 2004 |
ALTERED SIGNALING TRIGGERED BY LIGATION OF THE TCR/CD3 RECEPTOR IN T LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE ROAD FROM ANERGY TO AUTOIMMUNITY
AM Blasini, MA RODRíGUEZ |
International Reviews of Immunology | 2004 |
Decreased Expression of the CD3ζ Chain in T Cells Infiltrating the Synovial Membrane of Patients with Osteoarthritis
LI Sakkas, G Koussidis, E Avgerinos, J Gaughan, CD Platsoucas |
Clinical and vaccine immunology : CVI | 2004 |
T-cell receptor–induced phosphorylation of the ζ chain is efficiently promoted by ZAP-70 but not Syk
M Steinberg, O Adjali, L Swainson, P Merida, VD Bartolo, L Pelletier, N Taylor, N Noraz |
Blood | 2004 |
Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer?
Whiteside TL |
Cancer Immunology, Immunotherapy | 2004 |